For patients with bronchiectasis, some guidelines recommend mucoactive drugs plus airway clearance to enhance sputum expectoration, but evidence on this approach is limited. Research findings on the CLEAR trial are summarized in a new Quick Take video. nej.md/4qmNvyM
#MedSky #PulmSky
#MedSky #PulmSky
October 28, 2025 at 1:03 PM
Everybody can reply
7 likes
1 saves
In the CLEAR trial, neither carbocisteine nor hypertonic saline reduced the number of pulmonary exacerbations over a period of 52 weeks in participants with bronchiectasis. Full trial results and Research Summary: nej.md/3Vtn1h4
#MedSky #PulmSky #CriticalCare
#MedSky #PulmSky #CriticalCare
October 26, 2025 at 1:01 PM
Everybody can reply
3 reposts
13 likes
3 saves
I receive more and more #PeerReview requests where the subject is in my area but the statistical methods are much more complicated than I am comfortable assessing
#MedSky #PulmSky folks, what do you do in this case: accept or decline?
How do you make sure you don't miss something wrong?
#MedSky #PulmSky folks, what do you do in this case: accept or decline?
How do you make sure you don't miss something wrong?
October 16, 2025 at 3:34 PM
Everybody can reply
1 reposts
1 quotes
5 likes
Happy to share this review just out in Current Opinion in Immunology on innate immunity in the respiratory tract - also check out the other reviews in this collection on Intrinsic Immunity edited by John MacMicking #ImmunoSky #IDSky #pulmsky #MedSky www.sciencedirect.com/science/arti...
Layers of defense: protection from respiratory viruses by epithelial-intrinsic immunity
A central challenge in defending mucosal barriers is protecting against pathogens while also limiting excessive inflammation. Respiratory viruses are …
www.sciencedirect.com
October 13, 2025 at 3:26 PM
Everybody can reply
7 reposts
1 quotes
19 likes
1 saves
Patient required 2-3 l/m O2 via nasal cannula. Hemodynamics remained stable. A day later, he suffered massive intracranial hemorrhage and died...
Not every catheter-directed thrombolysis or suction thrombectomy is a success story!
#foamed #foamcc #meded #Medsky #emimcc #pulmsky
Not every catheter-directed thrombolysis or suction thrombectomy is a success story!
#foamed #foamcc #meded #Medsky #emimcc #pulmsky
October 10, 2025 at 8:11 PM
Everybody can reply
6 likes
Just submitted an abstract to @pvrinstitute.bsky.social PVRI 2026 Congress, at the last minute 😅
Fingers crossed 🤞🤞and see you in Dublin!
#PulmonaryHypertension #medsky #pulmsky
Fingers crossed 🤞🤞and see you in Dublin!
#PulmonaryHypertension #medsky #pulmsky
October 8, 2025 at 9:29 PM
Everybody can reply
1 likes
In critically ill patients, whether proportional-assist ventilation results in a shorter duration of mechanical ventilation than pressure-support ventilation is unclear. Research findings from the PROMIZING trial are summarized in a new Quick Take video. nej.md/3K4mK1C
#MedSky #PulmSky
#MedSky #PulmSky
September 21, 2025 at 7:00 PM
Everybody can reply
7 likes
1 saves
Drs. Michael Welsh, Jesús González, and Paul Negulescu have won the 2025 Lasker–DeBakey Clinical Medical Research Award for their roles in developing treatments for cystic fibrosis. Learn more: nej.md/41L3UCI
#MedSky #PulmSky #Genetics
#MedSky #PulmSky #Genetics
September 11, 2025 at 1:07 PM
Everybody can reply
5 reposts
1 quotes
17 likes
💡 Stay informed! Explore the latest ATS resources on measles, and tune into the new #BreatheEasy podcast discussing vaccine hesitancy here: https://buff.ly/4gXR34J
#VaccinesSaveLives #MedSky #pulmsky @idsainfo.bsky.social @btsrespiratory.bsky.social
#VaccinesSaveLives #MedSky #pulmsky @idsainfo.bsky.social @btsrespiratory.bsky.social
February 27, 2025 at 3:40 PM
Everybody can reply
1 reposts
Since we’re entering the last month of 2024, here is a non-systematic review of #pulmcrit trials published this year that I found particularly noteworthy. Not comprehensive, so please include any that I may have missed!
(🧵1/11)
#emimcc #critcare #pulmsky #medsky
(🧵1/11)
#emimcc #critcare #pulmsky #medsky
a man in a blue shirt and tie is standing in front of a bulletin board with papers on it .
ALT: a man in a blue shirt and tie is standing in front of a bulletin board with papers on it .
media.tenor.com
December 1, 2024 at 2:15 AM
Everybody can reply
24 reposts
2 quotes
72 likes
Lung anatomy, anyone? 🫁
#medsky
#pulmsky
@laurengroner.medsky.social
@gbosslet.bsky.social
@kerrijohannson.bsky.social
#medsky
#pulmsky
@laurengroner.medsky.social
@gbosslet.bsky.social
@kerrijohannson.bsky.social
January 26, 2025 at 4:09 PM
Everybody can reply
3 likes
Pressure support ventilation ( #PSV), aim of partially unloading the patient’s inspiratory muscles, over-assistance, under-assistance, patient self-inflicted lung injury ( #P-SILI), #pulmsky #emimcc #critcaresky
ccforum.biomedcentral.com/articles/10....
ccforum.biomedcentral.com/articles/10....
Pressure support, patient effort and tidal volume: a conceptual model for a non linear interaction - Critical Care
Pressure support ventilation (PSV) is a form of assisted ventilation which has become frequently used, with the aim of partially unloading the patient’s inspiratory muscles. Both under- and over-assis...
ccforum.biomedcentral.com
November 28, 2024 at 3:28 PM
Everybody can reply
5 reposts
10 likes
It’s an exciting time in #COPD! 2025 will be the year of biologics & personalised treatment for those who exacerbate despite stopping smoking, PR & triple therapy. #BTSWinter2024 #RespEd #pulmsky #medsky
November 27, 2024 at 9:44 AM
Everybody can reply
8 likes
Why read it? The trial provides clear evidence for the benefits of Azithromycin in patients with #asthma on LABA/ICS who continue to exacerbate. There is also a nice forest plot for fans of clear data communication! www.thelancet.com/journals/lan... #RespEd #pulmsky #medsky #lungsky
December 3, 2024 at 8:18 AM
Everybody can reply
1 reposts
1 likes
🚨🚨🔊🔊🔊
This weeks episode is about the use of biologic therapy in asthma!! See our one pager 👇
Listen here! 🔗 www.pulmpeeps.com/2025/04/22/9...
#pulmsky
This weeks episode is about the use of biologic therapy in asthma!! See our one pager 👇
Listen here! 🔗 www.pulmpeeps.com/2025/04/22/9...
#pulmsky
April 24, 2025 at 5:22 AM
Everybody can reply
1 reposts
3 likes
Carolyn Barber wrote:
He needed air. The price was $539.
When OptumRx dropped coverage of his $66 inhaler, Cole couldn’t afford the new price.
5 days later, he died from a severe asthma attack—with no inhaler.
He paid with his life.
www.nbcnews.com/nightly-news... #MedSky #SciSky #PedsSky #PulmSky
He needed air. The price was $539.
When OptumRx dropped coverage of his $66 inhaler, Cole couldn’t afford the new price.
5 days later, he died from a severe asthma attack—with no inhaler.
He paid with his life.
www.nbcnews.com/nightly-news... #MedSky #SciSky #PedsSky #PulmSky
22-year-old dies after being unable to afford asthma inhaler
In our new series “The Cost of Denial,” NBC News’ Anne Thompson reports on the young man who went to refill his asthma inhaler only to find it unaffordable because it was no longer covered by his insu...
www.nbcnews.com
June 4, 2025 at 11:14 AM
Everybody can reply
Did you know: the 9th edition TNM classification—effective since January 2025—is highlighted in @accpchest.bsky.social?
hubs.la/Q03zRGT00
#pulmsky
#radiology
#lungcancer
hubs.la/Q03zRGT00
#pulmsky
#radiology
#lungcancer
August 8, 2025 at 6:43 PM
Everybody can reply
A survey on inpatients views on the option of changing to a green inhaler - generally poorly informed about environmental impact but willing to give it a go! #BTSWinter2024 #pulmsky #medsky
November 27, 2024 at 2:43 PM
Everybody can reply
2 likes
Subunit vaccines may be conjugate, recombinant or toxoid. Diptheria, Tetanus & Pertussis are toxoid vaccines. Toxoids cause a strong immune responses, but are only possible for a small number of diseases vaccineknowledge.ox.ac.uk/types-of-vac... 10/n #RespEd #RespIsBest #PulmSky
Types of vaccine
vaccineknowledge.ox.ac.uk
November 18, 2024 at 9:45 AM
Everybody can reply
Vanzacaftor-tezacaftor-deutivacaftor versus elexacaftor-tezacaftor-ivacaftor in individuals with cystic fibrosis ag… pubmed.ncbi.nlm.nih.gov/39756424/
Vanzacaftor-tezacaftor-deutivacaftor versus elexacaftor-tezacaftor-ivacaftor in individuals with cystic fibrosis aged 12 years and older (SKYLINE Trials VX20-121-102 and VX20-121-103): results from tw...
Vertex Pharmaceuticals.
pubmed.ncbi.nlm.nih.gov
January 7, 2025 at 12:48 PM
Everybody can reply
1 reposts
1 likes
#EMIMCC #Pulmsky #POCUSky #Medsky #Cardiosky #Critcaresky
Fluid perils part1 & part2
www.pulmccm.org/p/primer-per...
www.pulmccm.org/p/primer-per...
Fluid perils part1 & part2
www.pulmccm.org/p/primer-per...
www.pulmccm.org/p/primer-per...
A Primer on the Perils of Intravenous Fluids – Part 1
Jon-Emile S.
www.pulmccm.org
March 9, 2025 at 10:30 AM
Everybody can reply
8 likes
And also happy to share recent work showing the potential of transcriptomics as clinical biomarkers, in this case drug response in Cystic Fibrosis, officially published @ajrcmb.bsky.social @atscommunity.bsky.social
Great work by a phenomenal team of collaborators!
#Medsky #Pulmsky #PedPulmSky
Great work by a phenomenal team of collaborators!
#Medsky #Pulmsky #PedPulmSky
November 27, 2024 at 10:41 PM
Everybody can reply
2 reposts
10 likes